CLINICAL_TRIALS
trial_result
· 2025-09-30
Clinical Trial Update: Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy [Phase 4]
Summary
Phase 4 rollover study of sacituzumab govitecan-hziy in participants with metastatic solid tumors; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Metastatic Solid Tumors | Phase 4 | Status: COMPLETED | Results posted: 2025-09-30